CARA logo

Cara Therapeutics (CARA) Current Assets

Annual Current Assets

$116.16 M
-$52.75 M-31.23%

31 December 2023

CARA Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$47.91 M
-$15.95 M-24.97%

30 September 2024

CARA Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CARA Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-31.2%-52.4%
3 y3 years-40.5%-72.1%
5 y5 years-30.9%-76.5%

CARA Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-40.5%at low-74.3%at low
5 y5 years-40.5%at low-76.5%at low
alltimeall time-40.5%+9359.1%-77.3%+3801.6%

Cara Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$47.91 M(-25.0%)
June 2024
-
$63.86 M(-21.4%)
Mar 2024
-
$81.22 M(-30.1%)
Dec 2023
$9.69 M(-27.3%)
$116.16 M(+15.5%)
Sept 2023
-
$100.60 M(-19.3%)
June 2023
-
$124.74 M(-12.6%)
Mar 2023
-
$142.66 M(-15.5%)
Dec 2022
$13.33 M(-81.9%)
$168.91 M(-9.6%)
Sept 2022
-
$186.78 M(+6.0%)
June 2022
-
$176.17 M(+16.1%)
Mar 2022
-
$151.76 M(-12.4%)
Dec 2021
$73.77 M(-3.1%)
$173.29 M(+1.0%)
Sept 2021
-
$171.50 M(+4.3%)
June 2021
-
$164.47 M(-12.7%)
Mar 2021
-
$188.35 M(-3.4%)
Dec 2020
$76.09 M(+13.1%)
$195.06 M(+46.8%)
Sept 2020
-
$132.84 M(-6.4%)
June 2020
-
$141.91 M(+7.0%)
Mar 2020
-
$132.67 M(-19.9%)
Dec 2019
$67.30 M(+196.7%)
$165.66 M(-18.6%)
Sept 2019
-
$203.46 M(+63.1%)
June 2019
-
$124.77 M(-13.4%)
Mar 2019
-
$144.16 M(-14.3%)
DateAnnualQuarterly
Dec 2018
$22.68 M(+1065.7%)
$168.14 M(-20.5%)
Sept 2018
-
$211.39 M(+52.6%)
June 2018
-
$138.53 M(+75.8%)
Mar 2018
-
$78.81 M(-17.1%)
Dec 2017
$1.95 M(-18.3%)
$95.06 M(-10.3%)
Sept 2017
-
$105.98 M(-8.5%)
June 2017
-
$115.81 M(+182.2%)
Mar 2017
-
$41.03 M(-33.2%)
Dec 2016
$2.38 M(+21.4%)
$61.45 M(-20.2%)
Sept 2016
-
$77.02 M(-13.6%)
June 2016
-
$89.14 M(-10.4%)
Mar 2016
-
$99.47 M(-8.7%)
Dec 2015
$1.96 M(-29.5%)
$108.93 M(-5.8%)
Sept 2015
-
$115.68 M(+162.7%)
June 2015
-
$44.03 M(-10.2%)
Mar 2015
-
$49.06 M(-7.7%)
Dec 2014
$2.79 M(-21.0%)
$53.15 M(-10.5%)
Sept 2014
-
$59.41 M(-8.7%)
June 2014
-
$65.06 M(-4.6%)
Mar 2014
-
$68.23 M(+368.6%)
Dec 2013
$3.52 M(-18.2%)
$14.56 M(-20.7%)
Sept 2013
-
$18.35 M(+1394.1%)
Dec 2012
$4.31 M(-29.7%)
$1.23 M
Dec 2011
$6.13 M
-

FAQ

  • What is Cara Therapeutics annual total current assets?
  • What is the all time high annual current assets for Cara Therapeutics?
  • What is Cara Therapeutics annual current assets year-on-year change?
  • What is Cara Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Cara Therapeutics?
  • What is Cara Therapeutics quarterly current assets year-on-year change?

What is Cara Therapeutics annual total current assets?

The current annual current assets of CARA is $116.16 M

What is the all time high annual current assets for Cara Therapeutics?

Cara Therapeutics all-time high annual total current assets is $195.06 M

What is Cara Therapeutics annual current assets year-on-year change?

Over the past year, CARA annual total current assets has changed by -$52.75 M (-31.23%)

What is Cara Therapeutics quarterly total current assets?

The current quarterly current assets of CARA is $47.91 M

What is the all time high quarterly current assets for Cara Therapeutics?

Cara Therapeutics all-time high quarterly total current assets is $211.39 M

What is Cara Therapeutics quarterly current assets year-on-year change?

Over the past year, CARA quarterly total current assets has changed by -$52.69 M (-52.38%)